Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Roberson

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Randomized trial of high- and low-source strength (125)I prostate seed implantsVrinda Narayana, Sara Troyer, Vicki Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Functional anatomy of the prostate: implications for treatment planningPatrick W McLaughlin, Sara Troyer, Sally Berri, et al.
Medical Physics|March 26, 2005
Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostatePeter L Roberson, P William McLaughlin, Vrinda Narayana, et al.
Physics in Medicine and Biology|April 29, 2008
Assessment of skin dose for breast chest wall radiotherapy as a function of bolus materialShu-Hui Hsu, Peter L Roberson, Yu Chen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parametersPeter L Roberson, Scott J Wilderman, Anca M Avram, et al.
Brachytherapy|September 18, 2004
The use of mutual information in registration of CT and MRI datasets post permanent implantPatrick W McLaughlin, Vrinda Narayana, Marc Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2019
Prediction of Tumor Control in <sup>90</sup>Y Radioembolization by Logit Models with PET/CT-Based Dose MetricsYuni K Dewaraja, Theresa Devasia, Ravi K Kaza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2010
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphomaPeter L Roberson, Hanan Amro, Scott J Wilderman, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 31, 2017
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin LymphomaPeter L Roberson, Lauren B Smith, Meredith A Morgan, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|January 5, 2005
Randomized trial of high- and low-source strength (125)I prostate seed implantsVrinda Narayana, Sara Troyer, Vicki Evans, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2005
Functional anatomy of the prostate: implications for treatment planningPatrick W McLaughlin, Sara Troyer, Sally Berri, et al.
Medical Physics|March 26, 2005
Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostatePeter L Roberson, P William McLaughlin, Vrinda Narayana, et al.
Physics in Medicine and Biology|April 29, 2008
Assessment of skin dose for breast chest wall radiotherapy as a function of bolus materialShu-Hui Hsu, Peter L Roberson, Yu Chen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 10, 2013
Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parametersPeter L Roberson, Scott J Wilderman, Anca M Avram, et al.
Brachytherapy|September 18, 2004
The use of mutual information in registration of CT and MRI datasets post permanent implantPatrick W McLaughlin, Vrinda Narayana, Marc Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 2019
Prediction of Tumor Control in <sup>90</sup>Y Radioembolization by Logit Models with PET/CT-Based Dose MetricsYuni K Dewaraja, Theresa Devasia, Ravi K Kaza, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 22, 2010
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphomaPeter L Roberson, Hanan Amro, Scott J Wilderman, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 31, 2017
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin LymphomaPeter L Roberson, Lauren B Smith, Meredith A Morgan, et al.
Pageof 3